DR. STEVEN PORTER, M.D., PH.D.
Osteopathic Medicine at Mountain View Ave, Mill Valley, CA
License number
California G065587
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
64 Mountain View Ave, Mill Valley, CA 94941
Phone
(415) 388-1052
Professional information
Dr. Steven B Porter, Mill Valley CA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
64 Mountain View Ave, Mill Valley 94941
(415) 388-1052 (Phone)
(415) 388-1052 (Phone)
Certifications:
Infectious Disease, 1994, Internal Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Vanderbilt University
Graduated: 1987
Vanderbilt University
Graduated: 1987
Therapeutic Composition
US Patent:
2010022, Sep 2, 2010
Filed:
Feb 26, 2010
Appl. No.:
12/713497
Inventors:
Steven B. Porter - Mill Valley CA, US
Williamson Ziegler Bradford - Ross CA, US
Patrick F. Smith - Pleasanton CA, US
Ellen S. Yetzer - San Francisco CA, US
Abel De La Rosa - Alpharetta GA, US
Michael D. Rogers - Chapell Hill NC, US
William T. Symonds - Cary NC, US
Williamson Ziegler Bradford - Ross CA, US
Patrick F. Smith - Pleasanton CA, US
Ellen S. Yetzer - San Francisco CA, US
Abel De La Rosa - Alpharetta GA, US
Michael D. Rogers - Chapell Hill NC, US
William T. Symonds - Cary NC, US
Assignee:
InterMune, Inc. - Brisbane CA
Roche Palo Alto LLC - Palo Alto CA
Pharmasset, Inc. - Princeton NJ
Roche Palo Alto LLC - Palo Alto CA
Pharmasset, Inc. - Princeton NJ
International Classification:
A61K 38/21, A61P 31/12, A61K 38/16, A61K 31/70, A61K 31/4965, A61K 31/505, A61P 1/16
US Classification:
424 855, 424 857, 514 12, 514 43, 51425505, 514274
Abstract:
Embodiments disclosed in the present application relate to a composition that can include a hepatitis C viral polymerase inhibitor, or pharmaceutically acceptable salt or prodrug thereof and a hepatitis C viral protease inhibitor, or pharmaceutically acceptable salt or prodrug thereof. Additional embodiments disclosed relate to methods for treating a disease condition such as a hepatitis C virus infection, liver fibrosis and/or impaired liver function with a hepatitis C viral polymerase inhibitor, or pharmaceutically acceptable salt or prodrug thereof and a hepatitis C viral protease inhibitor, or pharmaceutically acceptable salt or prodrug thereof.
Macrocyclic Inhibitors Of Hepatitis C Virus Replication
US Patent:
8048862, Nov 1, 2011
Filed:
Apr 14, 2009
Appl. No.:
12/423681
Inventors:
Scott D. Seiwert - Pacifica CA, US
Leonid Beigelman - San Mateo CA, US
Brad Buckman - Oakland CA, US
Antitsa Dimitrova Stoycheva - Half Moon Bay CA, US
Steven B. Porter - Mill Valley CA, US
Williamson Ziegler Bradford - Ross CA, US
Vladimir Serebryany - Burlingame CA, US
Leonid Beigelman - San Mateo CA, US
Brad Buckman - Oakland CA, US
Antitsa Dimitrova Stoycheva - Half Moon Bay CA, US
Steven B. Porter - Mill Valley CA, US
Williamson Ziegler Bradford - Ross CA, US
Vladimir Serebryany - Burlingame CA, US
Assignee:
InterMune, Inc. - Brisbane CA
International Classification:
A61K 38/21, A61K 31/4709, A61K 31/7056, A61K 31/4738, A61K 31/407, A61K 31/4725, A61K 31/517, A61K 31/403, C07D 245/04, C07D 209/02
US Classification:
514 43, 514312, 514285, 514411, 514309, 5142662, 514336, 514365, 514414, 540460, 424 855, 424 857, 548465
Abstract:
The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
US Patent:
2011005, Mar 10, 2011
Filed:
Nov 18, 2010
Appl. No.:
12/949700
Inventors:
Scott D. Seiwert - Pacifica CA, US
Leonid Beigelman - San Mateo CA, US
Brad Buckman - Oakland CA, US
Antitsa Dimitrova Stoycheva - Half Moon Bay CA, US
Steven B. Porter - Mill Valley CA, US
Williamson Ziegler Bradford - Ross CA, US
Vladimir Serebryany - Burlingame CA, US
Leonid Beigelman - San Mateo CA, US
Brad Buckman - Oakland CA, US
Antitsa Dimitrova Stoycheva - Half Moon Bay CA, US
Steven B. Porter - Mill Valley CA, US
Williamson Ziegler Bradford - Ross CA, US
Vladimir Serebryany - Burlingame CA, US
Assignee:
InterMune, Inc. - Brisbane CA
International Classification:
A61K 38/12, C07K 5/12, A61K 38/21, A61P 31/14
US Classification:
424 857, 530323, 514 211, 514 43, 424 854
Abstract:
The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.